420 Progression-free survival and biomarker correlates of response with BEMPEG plus NIVO in previously untreated patients with metastatic melanoma: results from the PIVOT-02 study
- Publication date
- 1 January 2020
- Publisher
- Providence St. Joseph Health Digital Commons